|
|
|
Volumn 32, Issue 4, 2007, Pages 234-
|
|
Alemtuzumab (Campath) or standard treatment with chlorambucil (Leukeran) for B-cell chronic lymphocytic leukemia
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALEMTUZUMAB;
CHLORAMBUCIL;
ANEMIA;
CANCER GROWTH;
CANCER SURVIVAL;
CHILL;
CHRONIC LYMPHATIC LEUKEMIA;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG EFFICACY;
FEVER;
HUMAN;
INFECTION;
MULTIPLE CYCLE TREATMENT;
NAUSEA;
NEUTROPENIA;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
URTICARIA;
VOMITING;
|
|
EID: 34248334661
PISSN: 10521372
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (4)
|
|
References (1)
|
